LANDMARK INTERNATIONAL COLLABORATION CREATES A FOUNDATION FOR DRUG DEVELOPMENT IN YOUNG ADULT CANCER CALLED CCS, OPENING THE DOOR TO NEW POTENTIAL THERAPY
/PRNewswire/ Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its.